News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

John Kulze, MD

Articles by John Kulze, MD

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

ByWilliam C. Stewart, MD,Jessica Leech, BS,Elizabeth D. Sharpe, MD,John Kulze, MD,John Ellyn, MD,Douglas G. Day, MD

August 1st 2002

Latest Updated Articles

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension
Published: August 1st 2002 | Updated:

Trending on AJMC

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

ACE Inhibitors Linked to Reduced Mortality in Patients with Idiopathic Pulmonary Fibrosis

5 Ongoing Phase 3 Trials in Hematologic Malignancies

Clinical Trial Data Signal a New Era for Atopic Dermatitis, Melanoma, and Psoriasis

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.